The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in ...

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study ...

New study reveals UV radiation and Merkel cell polyomavirus as leading risk factors for Merkel cell carcinoma. Learn how ...

A study analyzing over 660,000 skin cancer cases highlighted significant risk factors. incidence and mortality for MCC and ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the US Food and ...

65.1% and 63.8% of Merkel cell carcinoma cases were attributed to ambient ultraviolet radiation exposure and Merkel cell polyomavirus. 2.5% were traced to HIV, organ transplants and chronic ...

Research demonstrates that AI can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by generating personalzsed ...

Vilastobart is under clinical development by Xilio Therapeutics and currently in Phase II for Merkel Cell Carcinoma.

Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.” ...

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, ...

Researchers have developed AI, called DeepMerkel, which can determine the course and severity of aggressive skin cancers ...